EP3626273
And-cMet mótefnis-lyfjaafleiður og aðferðir til að nota þær
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
17.5.2017EP published:
30.12.2020EP application number:
19197371.8
EP translation filed:
27.1.2021Grant published:
15.2.2021EPO information:
European Patent Register
Max expiry date:
16.5.2037Expiry date:
16.5.2026Next due date:
31.5.2026
Title:
ANTI-CMET ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE
Timeline
Today
17.5.2017EP application
30.12.2020EP Publication
27.1.2021Translation submitted
15.2.2021Registration published
16.5.2026Expires
Owner
Name:
AbbVie Manufacturing Management Unlimited CompanyAddress:
70 Sir John Rogerson’s Quay, Dublin D02 R296, IE
Inventor
Name:
REILLY, Edward BAddress:
Libertyville, IL 60048, US
Name:
NAUMOVSKI, LouieAddress:
Los Altos, CA 94022, US
Name:
ALLAN, Christian B.Address:
San Mateo, CA 94403, US
Name:
WANG, JieyiAddress:
Belmont, CA 94002, US
Name:
ANDERSON, Mark G.Address:
Grayslake, IL 60030, US
Name:
AFAR, Daniel E.Address:
Los Altos Hills, CA 94022, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662337796 PDate:
17.5.2016Country:
US
Classification
Categories:
A61K 47/68
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 12.4.2021
Expires: 16.5.2022
Payer: Örn Þór slf.
Number: 6
Paid: 22.4.2022
Expires: 16.5.2023
Payer: Árnason Faktor ehf.
Number: 7
Paid: 12.4.2023
Expires: 16.5.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 12.4.2024
Expires: 16.5.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 6.5.2025
Expires: 16.5.2026
Payer: Árnason Faktor ehf.